Your browser doesn't support javascript.
loading
Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology.
Moura, Brenda; Aimo, Alberto; Al-Mohammad, Abdallah; Flammer, Andreas; Barberis, Vassilis; Bayes-Genis, Antoni; Brunner-La Rocca, Hans-Peter; Fontes-Carvalho, Ricardo; Grapsa, Julia; Hülsmann, Martin; Ibrahim, Nasrien; Knackstedt, Christian; Januzzi, James L; Lapinskas, Tomas; Sarrias, Axel; Matskeplishvili, Simon; Meijers, Wouter C; Messroghli, Daniel; Mueller, Christian; Pavo, Noemi; Simonavicius, Justas; Teske, Arco J; van Kimmenade, Roland; Seferovic, Petar; Coats, Andrew J S; Emdin, Michele; Richards, A Mark.
Afiliación
  • Moura B; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Aimo A; Cardiology Department, Porto Armed Forces Hospital, Porto, Portugal.
  • Al-Mohammad A; Scuola Superiore Sant'Anna, and Fondazione G. Monasterio, Pisa, Italy.
  • Flammer A; Medical School, University of Sheffield and Sheffield Teaching Hospitals, Sheffield, UK.
  • Barberis V; Cardiology, University Hospital Zurich, Zurich, Switzerland.
  • Bayes-Genis A; American Medical Center, American Heart Institute, Nicosia, Cyprus.
  • Brunner-La Rocca HP; Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Fontes-Carvalho R; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
  • Grapsa J; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Hülsmann M; Cardiovascular Research and Development Unit (UnIC), Faculty of Medicine University of Porto, Porto, Portugal.
  • Ibrahim N; Cardiology Department, Centro Hospitalar de Vila Nova Gaia/Espinho, Espinho, Portugal.
  • Knackstedt C; Department of Cardiology, Guys and St Thomas NHS Hospitals Trust, London, UK.
  • Januzzi JL; Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Lapinskas T; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Sarrias A; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Matskeplishvili S; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Meijers WC; Department of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Messroghli D; Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Mueller C; Lomonosov Moscow State University Medical Centre, Moscow, Russia.
  • Pavo N; University Medical Centre Groningen, Groningen, The Netherlands.
  • Simonavicius J; Department of Internal Medicine-Cardiology, Deutsches Herzzentrum Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Teske AJ; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
  • van Kimmenade R; Department of Internal Medicine, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
  • Seferovic P; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Coats AJS; Vilnius University Hospital Santaros klinikos, Vilnius, Lithuania.
  • Emdin M; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Richards AM; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Eur J Heart Fail ; 23(10): 1577-1596, 2021 10.
Article en En | MEDLINE | ID: mdl-34482622
Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiología / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Portugal Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiología / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Portugal Pais de publicación: Reino Unido